Mark For: ADMAX® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76045485 |
Registration Number | 2708330 |
Mark Literal Elements | ADMAX |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | SCANNING ON DEMAND 2007-12-26 |
Basis | 1(a) |
Class Status | SECTION 8 - CANCEL |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Cancellation Code | 2 |
Attorney Name | Gerard H. Bencen |
Attorney Docket Number | FG-TMI |
Law Office Assigned | L50 |
Employee Name | JENKINS JR, CHARLES L |
2000-04-03 | Date of First Use |
2000-04-05 | Date of Use In Commerce |
2000-05-10 | Application Filed |
2003-01-28 | Published |
2003-01-28 | Published for Opposition |
2003-04-22 | Trademark Registered |
2007-12-26 | Location: SCANNING ON DEMAND |
2009-11-28 | Cancelled |
2009-11-28 | Status: Dead/Cancelled |
2009-11-28 | Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | 34 Amelia Street Hamilton, ONTARIO CANADA L8P 2V4 |
Legal Entity Type | Individual |
![]() | IMAGE/TIFF | 2000-05-10 |
![]() | IMAGE/TIFF | 2000-05-10 |
![]() | IMAGE/TIFF | 2000-05-10 |
![]() | 2002-11-05 | |
![]() | 2003-01-08 | |
![]() | 2003-04-22 | |
![]() | 2003-04-22 | |
![]() | 2007-12-19 | |
![]() | 2007-12-19 | |
![]() | 2007-12-19 |
(CANCELLED)
IC 001. US 001 005 006 010 026 046. G & S: Nucleic acid preparations, namely adenoviral vectors for scientific and commercial use; adenoviral kits comprised of plasmids; adenoviral kits comprised of adenoviral vectors; adenoviral kits comprised of plasmids and cells; adenoviral kits comprised of adenoviral vectors and cells, all for scientific and commercial use. FIRST USE: 20000403. FIRST USE IN COMMERCE: 20000405
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
Type Code | Type |
---|---|
GS0011 | Nucleic acid preparations, namely adenoviral vectors for scientific and commercial use; adenoviral kits comprised of plasmids; adenoviral kits comprised of adenoviral vectors; adenoviral kits comprised of plasmids and cells; adenoviral kits comprised of adenoviral vectors and cells, all for scientific and commercial use |
Description | Date | Proceeding Number |
---|---|---|
CANCELLED SEC. 8 (6-YR) | 2009-11-28 | |
CASE FILE IN TICRS | 2007-12-26 | |
REGISTERED-PRINCIPAL REGISTER | 2003-04-22 | |
PUBLISHED FOR OPPOSITION | 2003-01-28 | |
NOTICE OF PUBLICATION | 2003-01-08 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-11-26 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-10-24 | |
NON-FINAL ACTION MAILED | 2002-06-24 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-01-03 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-10-10 | |
NON-FINAL ACTION MAILED | 2001-07-03 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-03-26 | |
NON-FINAL ACTION MAILED | 2000-10-16 | |
ASSIGNED TO EXAMINER | 2000-09-28 | 72150 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.